Detalles de la búsqueda
1.
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
J Urol
; 203(6): 1163-1171, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895002
2.
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR).
BMC Geriatr
; 20(1): 109, 2020 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32183741
3.
A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments.
Neurourol Urodyn
; 37(1): 177-185, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370541
4.
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER).
Health Qual Life Outcomes
; 16(1): 69, 2018 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29673355
5.
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
Int Urogynecol J
; 29(2): 273-283, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620791
6.
A randomized trial of Plasma-Lyte A and 0.9 % sodium chloride in acute pediatric gastroenteritis.
BMC Pediatr
; 16: 117, 2016 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27480410
7.
8.
Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
Crit Care
; 19: 334, 2015 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26370823
9.
Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial.
Ann Surg
; 259(2): 255-62, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23732264
10.
Evaluation of distracting pain and clinical judgment in cervical spine clearance of trauma patients.
World J Surg
; 37(1): 127-35, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23052795
11.
Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.
Ann Surg
; 255(5): 821-9, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22470070
12.
Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.
Crit Care
; 20: 17, 2016 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26792222
13.
Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder.
Pharmacoecon Open
; 5(1): 45-55, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32291728
14.
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet.
Drugs Aging
; 37(9): 665-676, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725584
15.
Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR).
Eur Urol
; 77(2): 211-220, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733990
16.
Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries.
Adv Ther
; 37(8): 3584-3605, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638205
17.
Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis.
Drugs Aging
; 37(11): 801-816, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960422
18.
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
Adv Ther
; 36(8): 1906-1921, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31222714
19.
A clustering of injury behaviors.
J Trauma
; 65(5): 1000-4, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001964
20.
Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome.
J Am Soc Hypertens
; 12(11): 768-778.e1, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181042